References
Adam von D, Konig J. Gewebekonzentrationen von ceftizoxim in der lungs. Arzneimittel-Forschung 33: 427–429, 1983
Imaizumi M, Uchida T, Akiyama S, Hiray K, Ichimura I, et al. The concentration of ceftizoxime in serum and lung tissues and prophylaxis of postoperative infections. Japanese Journal of Antibiotics 38: 1661–1670, 1985
Lo Cicero S, Meinardi G, Garotta F, Cimono G, Grilli R, et al. Ceftizoxima nelle pneumopatie batteriche: efficacia clinica e livelli nel sangue e nel secreto bronchiale. Lotta contro la TBC e malattie polmonari 56: 943–946, 1986
Lou MA, Wu YH, Parks DB, Pitkin D. Penetration of ceftizoxime in human breast milk, various body fluids and tissues. Proceedings of the 13th International Congress of Chemotherapy, Vienna, August, 1983
Mandai AK, Lou MA, Thadepalli H. Penetration of ceftizoxime and cefonicid into the human pleural fluid. Proceedings of the 13th International Congress of Chemotherapy, Vienna, August, 1983
Matsumoto K, Shishido H, Nagatake T, Uzuka Y, Taguchi M, et al. Clinical and laboratory evaluation of ceftizoxime, a new syn methoxyimino cephalosporin antibiotic, with special reference to respiratory infections due to Haemophilus influenzae and Streptococcus pneumoniae. Chemotherapy (Tokyo) 28: 447–462, 1980
Nakatomi M, Saito A, Nasu M, Yamaguchi K, Shigeno Y, et al. In vitro activity, serum and sputum levels, and clinical effectiveness of ceftizoxime, a new parenteral cephalosporin. In Periti P, Grassi GG (Eds) Current chemotherapy and immunotherapy. Proceedings of the 12th International Congress of Chemotherapy, Florence, pp. 400–406, 1981, American Society for Microbiology, Washington, DC, 1982
Takamoto M, Ishibashi T, Harada S, Harada Y. Experience with ceftizoxime in respiratory tract infection and its transfer into pleural effusion. Chemotherapy (Tokyo) 28 (Suppl. 5): 394–404, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clini, V., Clini, E., Tana, F. et al. Ceftizoxime in Lower Respiratory Tract Infection. Drug Invest 4 (Suppl 1), 38–39 (1992). https://doi.org/10.1007/BF03258344
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03258344